SynthesisBreast cancer research and treatment2026
Fertility preservation in breast cancer patients: a systematic review and summary of current evidence and recommendations.
Synthesis in Breast cancer research and treatment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundWith the rising survival rates of breast cancer, fertility preservation has become a paramount concern for young patients throughout their anticancer treatment. We conducted a systematic review to assess and synthesize evidence and recommendations on fertility preservation in breast cancer patients to provide evidence-based clinical guidance.
methodsAccording to the '6S' evidence resource model, evidence retrieval is searched from the top-down and collected relevant clinical decisions, guidelines, evidence summaries, expert consensus, recommended practices, and systematic reviews. The retrieval time limit was from the database establishment to July 2025. Two reviewers independently screened and evaluated the literature, and then extracted and summarized the evidence according to the JBI grading of evidence and recommendation system.
resultsA total of 47 publications were finally included, including 14 guidelines, 9 expert consensus, 7 recommended practices, and 17 systematic reviews. Through the induction and integration of the evidence, the evidence was finally summarized from ten aspects: treatment-related factors for fertility impairment, risk assessment of fertility impairment, genetic risk assessment and intervention, fertility preservation counseling and management, target population for fertility preservation, fertility preservation protocols, surgical treatment and fertility, post-treatment pregnancy management, post-treatment breastfeeding management and contraceptive management, and totally 50 best available evidence were formed.
conclusionsThis study summarized the best available evidence for fertility preservation in breast cancer patients from ten aspects, which can provide guidance for clinical medical staff to develop individualized fertility preservation plans and assist patients in making fertility preservation decisions, ultimately supporting young breast cancer patients in achieving the dual goals of survival and future parenthood.
Indexed as
Identifiers
41627574What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.